Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/05/1998WO1998048781A1 Controlled release of drugs delivered by sublingual or buccal administration
11/05/1998WO1998048780A1 Vesicular complexes and methods of making and using the same
11/05/1998WO1998048772A1 Personal care compositions comprising a silicone-containing adhesive copolymer
11/05/1998WO1998048716A1 Method for removing superfluous hairs
11/05/1998WO1998048630A1 Method of treating malignancies
11/05/1998WO1998048629A1 Non-spherical and non-platelet pyrithione salts
11/05/1998WO1998048627A1 Teat dipping agent
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998042312A3 Medicament having sclerosing activity
11/05/1998WO1998039293A3 13-thia prostaglandins for use in glaucoma therapy
11/05/1998WO1998037091A3 Modified retinoblastoma tumor suppressor proteins
11/05/1998WO1998034602A3 Mediation of cytokines by melanin
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998WO1998033798A3 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
11/05/1998WO1998027929A3 Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
11/05/1998WO1998013349A3 Heteroaryloxyethylamines as 5-ht1a ligands
11/05/1998DE19810383A1 Anti-neoplastic therapy uses of 4-phenyl butyrate or its derivatives,
11/05/1998DE19724752A1 Use of carbazol-4-yl-oxy-propanol-amine derivative
11/05/1998DE19720151A1 Chimäre Oligonucleotide und ihre Verwendung Chimeric oligonucleotides and their use
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2614617A1 Pourable alginate compositions
11/05/1998CA2539919A1 Compositions of aminosugars or fragments of glycosaminoglycans with s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2539696A1 Compositions of aminosugars, glycosaminoglycans and s-adenosylmethionine for the treatment or repair of connective tissue in mammals
11/05/1998CA2496680A1 Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
11/05/1998CA2291775A1 Vanadium complexes and derivatives thereof and methods related thereto
11/05/1998CA2291056A1 Non-spherical and non-platelet pyrithione salts
11/05/1998CA2289454A1 Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
11/05/1998CA2289257A1 Therapeutic treatment for skin disorders
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288897A1 Aminotetralins as 5-ht1d.alpha. agonists
11/05/1998CA2288431A1 Cadherin-11 as an indicator of viable pregnancy
11/05/1998CA2288308A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998CA2288224A1 Antithrombotic agents
11/05/1998CA2288209A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998CA2288154A1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998CA2288144A1 Antithrombotic agents
11/05/1998CA2288089A1 Hair spray compositions
11/05/1998CA2288030A1 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
11/05/1998CA2287993A1 Antithrombotic agents
11/05/1998CA2287989A1 Protease inhibitors
11/05/1998CA2287984A1 Antithrombotic agents
11/05/1998CA2287982A1 Antithrombotic agents
11/05/1998CA2287980A1 Antithrombotic agents
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways
11/05/1998CA2287901A1 Antithrombotic agents
11/05/1998CA2287862A1 Cytotoxic compounds: derivatives of the pyrido¬2,3,4-kl| acridine ring system
11/05/1998CA2287567A1 Protease inhibitors
11/05/1998CA2287436A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998CA2287318A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998CA2287244A1 Indene compounds having activity as serms
11/05/1998CA2286232A1 Dna-binding pyrrole and imidazole polyamide derivatives
11/05/1998CA2285948A1 Method and composition for modulating amyloidosis
11/05/1998CA2285678A1 Method for removing superfluous hairs
11/05/1998CA2285402A1 Amide derivatives, their production and use
11/05/1998CA2281789A1 Topical nasal antiinflammatory compositions
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998CA2259327A1 Teat dipping agent
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875515A2 "Sulfatation of estrogen mixtures"
11/04/1998EP0875514A1 Ascorbic acid derivative and vitamin C preparation containing the same
11/04/1998EP0875513A1 Substituted heteroaromatic 5-HT 1F agonists
11/04/1998EP0875512A2 New naphthylpiperazine derivatives with antipsychotic activity
11/04/1998EP0875511A1 Demethylation process for preparing benzo[b]thiophenes
11/04/1998EP0875508A1 Method for the preparation of baccatin III and derivatives thereof from 10-deacetylbaccatin III
11/04/1998EP0875506A1 Quinoline and quinazoline compounds useful in therapy
11/04/1998EP0875501A2 Alkylenediamine derivative, anti-ulcer drug, and antibacterial drug
11/04/1998EP0875500A2 Quaternised fatty acid amido-amine-etoxylates
11/04/1998EP0875499A2 Process for the crystallisation of alkali metal salts of diformylamide
11/04/1998EP0875495A1 New derivatives of salicylic acid and their use in cosmetic and/or dermatological compositions
11/04/1998EP0875254A1 Agent for prevention and depression of dry coughing caused by angiotensin converting enzyme inhibitors
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0875248A1 Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
11/04/1998EP0875247A1 Method for controlling the plasma level of lipoproteins
11/04/1998EP0875246A1 Pharmaceutical preparation of ascorbic acid derivatives for medical treatment of cancer
11/04/1998EP0875155A1 Peri-operative drink
11/04/1998EP0874910A1 Peptide-enhanced cationic lipid transfections
11/04/1998EP0874905A1 Novel tcts response regulator of staphylococcus aureus
11/04/1998EP0874864A1 Osteo antiviral protein
11/04/1998EP0874863A1 3-deoxy-3-descladinose derivatives of erythromycins a and b
11/04/1998EP0874861A1 Synthetic multivalent slex containing polylactosamines and methods for use
11/04/1998EP0874855A1 Production of a salt of clavulanic acid
11/04/1998EP0874854A2 Cephalosporin antibiotics
11/04/1998EP0874853A1 Process for preparation of cefdinir
11/04/1998EP0874852A1 Oxazolidinone antibacterial agent with tricyclic substituents
11/04/1998EP0874851A2 Macrocyclic compounds made from suboxide units
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998EP0874848A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
11/04/1998EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
11/04/1998EP0874846A1 Purine derivatives and processes for their preparation
11/04/1998EP0874845A1 Pyrido (2,3-b) pyrazine derivatives
11/04/1998EP0874844A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/04/1998EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
1 ... 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 ... 7860